Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Wall Cecil CDirector | Grant or award | A | $18K 23.1K sh | Jan 8, 2026 |
| 15 | Marathe AjayChief Operating Officer | Tax withholding | F | $369K 42.6K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 14 | Schlosser MarioDirector, President of Technology & CTO | Open-market sale · 10b5-1 plan | SELL | $1.31M 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 14 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $234K 3,016 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Parker Mark SPresident | Tax withholding | F | $2,525 1,672 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Lopez Anthony WilliamSEE REMARKS | Tax withholding | F | $35K 7,768 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Ackerman EricaCAO and Corporate Controller | Tax withholding | F | $1,037 687 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Smith Chad M.Pres & COO, Better Mortgage | Open-market sale · 10b5-1 plan | SELL | $100K 2,843 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Kouzoukas Demetrios L.Director | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Arnaboldi Nicole SDirector | Grant or award | A | $36K 463 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Foote TimChief Financial Officer | Option exercise | M | — 4,616 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $34K 4,364 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Willis Eric M.See Remarks | Option exercise | M | — 29.5K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Lizzul Paul F.Chief Medical Officer | Option exercise | M | — 6,145 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Loengard Anna UDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Robinson William G JrDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Lopez Anthony WilliamSEE REMARKS | Option exercise | M | — 17.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Nelson Jonathan PChief Operations Officer | Tax withholding | F | $30K 32.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | M | — 17.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Lufkin Paul AndrewSenior Vice President, Sales | Tax withholding | F | $28K 30.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Boone KarenDirector | Option exercise | M | — 1,460 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | F | $136K 17.6K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $830K 4,783 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $280K 1,615 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $493K 2,830 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Giroux RichardCFO & COO | Tax withholding | F | $223K 28.8K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | F | $52K 6,729 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 11 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $116K 1,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 11 | Shipchandler KhozemaDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $290K 2,181 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 11 | Peters John SheldonChief Insurance Officer | Open-market sale · 10b5-1 plan | SELL | $800K 10.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 11 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,900 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Dishart NoreenExecutive VP/Chief HR Officer | Grant or award | A | — 18.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 67 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | M | — 17.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 4,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 451 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Warnica Kimberly O.EVP, CLO & Secretary | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 589 sh | Jan 8, 2026 traded Jan 6, 2026 |